Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

NCT07146113 · clinicaltrials.gov ↗
RECRUITING
Status
400
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca